全体要約
希少神経疾患治療市場は、2022年の売上高を基に、2023年から2029年にかけての地域別および市場セクター別の予測を提供します。市場は生物製剤や有機化合物に分類され、病院薬局、小売薬局、オンライン薬局での応用が考慮されています。アメリカ、ヨーロッパ、中国などの主要地域での成長が見込まれています。
主要企業には、ファイザー、アラガン、ノバルティス、バイエル、メドトロニック、サノフィ、ジョンソン・エンド・ジョンソン、テバ製薬が含まれ、2022年には上位2社が市場の大部分を占めました。市場の成長機会やシェア、戦略が詳細に分析され、希少神経疾患治療の動向が明らかにされています。
関連する質問
Pfizer, Allergan, Novartis, Bayer Aktiengesellschaft, Medtronic, Sanofi, Johnson & Johnson, Teva Pharmaceutical
製品セグメンテーションの重要なトレンド, 企業の形成と市場シェア, 地理的フットプリントの分析
概要
このインサイトレポートは、世界の希少神経疾患治療の状況に関する包括的な分析を提供し、製品セグメンテーション、企業の形成、収益、市場シェア、最新の開発、M&A活動に関連する重要なトレンドを強調します。また、このレポートでは、希少神経疾患治療ポートフォリオや能力、市場参入戦略、市場ポジション、地理的な展開に焦点を当てて、主要なグローバル企業の戦略を分析し、加速する世界の希少神経疾患治療市場におけるこれらの企業の独自の位置をよりよく理解できるようにします。
このインサイトレポートは、希少神経疾患治療に関する世界的な展望を形作る主要な市場動向、ドライバー、および影響因子を評価し、タイプ別、アプリケーション別、地理的要因別、市場規模別に予測を分解して新たな機会のポケットを浮き彫りにします。数百のボトムアップの定性的および定量的な市場インプットに基づいた透明な方法論により、この研究予測は、世界の希少神経疾患治療における現在の状態と将来の軌道に関する非常に詳細な見解を提供します。
世界の希少神経疾患治療市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長する見込みです。2023年から2029年までの間にCAGR%で成長すると予想されています。
アメリカ合衆国における希少神経疾患治療市場は、2022年のXX米ドルから2029年までにXX米ドルに増加することが見込まれており、2023年から2029年までの間にXX%の年平均成長率（CAGR）が予測されます。
中国における希少神経疾患治療市場は、2022年のXX米ドルから2029年までにXX米ドルに増加する見込みで、2023年から2029年の間にXX%のCAGRを記録する予定です。
ヨーロッパの希少神経疾患治療市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると見込まれています。また、2023年から2029年までの期間で年平均成長率（CAGR）はXX%です。
世界の主要な希少神経疾患治療のプレーヤーには、ファイザー、アラガン、ノバルティス、バイエル、メドトロニック、サノフィ、ジョンソン・エンド・ジョンソン、テバ・ファーマシューティカルなどが含まれます。収益の観点から、2022年には世界の2大企業がほぼXX%のシェアを占めました。
この報告書は、希少神経疾患治療市場の製品タイプ、アプリケーション、主要プレイヤー、主要地域および国による包括的な概要、市場シェア、および成長機会を示しています。
市場セグメンテーション
種類別セグメンテーション
バイオロジクス
有機化合物
アプリケーション別のセグメンテーション
病院薬局
小売薬局
オンライン薬局
この報告書では、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から集めた情報と企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されています。
ファイザー
アラガン
ノバルティス
バイエル株式会社
メドトロニック
サノフィ
ジョンソン・エンド・ジョンソン
テバ製薬
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの希少神経疾患治療市場規模、（2018年～2029年）
2.1.2 希少神経疾患治療市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 希少神経疾患治療セグメント、タイプ別
2.2.1 生物製剤
2.2.2 有機化合物
2.3 希少神経疾患治療市場規模：タイプ別
2.3.1 希少神経疾患治療市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの希少神経疾患治療市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 希少神経疾患治療セグメント、用途別
2.4.1 病院内薬局
2.4.2 小売薬局
2.4.3 オンライン薬局
2.5 希少神経疾患治療市場規模：用途別
2.5.1 希少神経疾患治療市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの希少神経疾患治療市場規模、市場シェア（用途別）（2018年～2023年）
3 希少神経疾患治療市場規模：プレイヤー別
3.1 希少神経疾患治療市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける希少神経疾患治療市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける希少神経疾患治療市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの希少神経疾患治療市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 希少神経疾患治療、地域別
4.1 希少神経疾患治療市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける希少神経疾患治療市場規模成長（2018年〜2023年）
4.3 APACにおける希少神経疾患治療市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける希少神経疾患治療市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける希少神経疾患治療市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける希少神経疾患治療市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける希少神経疾患治療市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける希少神経疾患治療市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける希少神経疾患治療市場規模、地域別（2018年〜2023年）
6.2 APACにおける希少神経疾患治療市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける希少神経疾患治療市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの希少神経疾患治療 国別（2018年～2023年）
7.2 ヨーロッパにおける希少神経疾患治療市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける希少神経疾患治療市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの希少神経疾患治療 地域別（2018年～2023年）
8.2 中東・アフリカにおける希少神経疾患治療市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける希少神経疾患治療市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの希少神経疾患治療市場、市場予測
10.1 グローバルの希少神経疾患治療、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの希少神経疾患治療、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの希少神経疾患治療、市場予測
10.1.3 APACの希少神経疾患治療、市場予測
10.1.4 ヨーロッパの希少神経疾患治療、市場予測
10.1.5 中東・アフリカの希少神経疾患治療、市場予測
10.2 アメリカズの希少神経疾患治療、市場予測（国別）（2024年～2029年）
10.3 APACの希少神経疾患治療、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの希少神経疾患治療、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの希少神経疾患治療、市場予測（地域別）（2024年～2029年）
10.6 グローバルの希少神経疾患治療、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの希少神経疾患治療、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Pfizer
11.1.1 Pfizer：企業情報
11.1.2 Pfizer：希少神経疾患治療分野の提供製品
11.1.3 Pfizer：希少神経疾患治療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 Pfizer：主要事業概要
11.1.5 Pfizer：直近の展開
11.2 Allergan
11.2.1 Allergan：企業情報
11.2.2 Allergan：希少神経疾患治療分野の提供製品
11.2.3 Allergan：希少神経疾患治療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 Allergan：主要事業概要
11.2.5 Allergan：直近の展開
11.3 Novartis
11.3.1 Novartis：企業情報
11.3.2 Novartis：希少神経疾患治療分野の提供製品
11.3.3 Novartis：希少神経疾患治療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Novartis：主要事業概要
11.3.5 Novartis：直近の展開
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft：企業情報
11.4.2 Bayer Aktiengesellschaft：希少神経疾患治療分野の提供製品
11.4.3 Bayer Aktiengesellschaft：希少神経疾患治療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 Bayer Aktiengesellschaft：主要事業概要
11.4.5 Bayer Aktiengesellschaft：直近の展開
11.5 Medtronic
11.5.1 Medtronic：企業情報
11.5.2 Medtronic：希少神経疾患治療分野の提供製品
11.5.3 Medtronic：希少神経疾患治療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.5.4 Medtronic：主要事業概要
11.5.5 Medtronic：直近の展開
11.6 Sanofi
11.6.1 Sanofi：企業情報
11.6.2 Sanofi：希少神経疾患治療分野の提供製品
11.6.3 Sanofi：希少神経疾患治療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 Sanofi：主要事業概要
11.6.5 Sanofi：直近の展開
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson：企業情報
11.7.2 Johnson & Johnson：希少神経疾患治療分野の提供製品
11.7.3 Johnson & Johnson：希少神経疾患治療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 Johnson & Johnson：主要事業概要
11.7.5 Johnson & Johnson：直近の展開
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical：企業情報
11.8.2 Teva Pharmaceutical：希少神経疾患治療分野の提供製品
11.8.3 Teva Pharmaceutical：希少神経疾患治療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 Teva Pharmaceutical：主要事業概要
11.8.5 Teva Pharmaceutical：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Rare Neurological Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rare Neurological Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rare Neurological Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rare Neurological Disease Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rare Neurological Disease Treatment.
The global Rare Neurological Disease Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rare Neurological Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rare Neurological Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rare Neurological Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rare Neurological Disease Treatment players cover Pfizer, Allergan, Novartis, Bayer Aktiengesellschaft, Medtronic, Sanofi, Johnson & Johnson and Teva Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Rare Neurological Disease Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Biologics
Organic Compounds
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Allergan
Novartis
Bayer Aktiengesellschaft
Medtronic
Sanofi
Johnson & Johnson
Teva Pharmaceutical
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rare Neurological Disease Treatment Market Size 2018-2029
2.1.2 Rare Neurological Disease Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Rare Neurological Disease Treatment Segment by Type
2.2.1 Biologics
2.2.2 Organic Compounds
2.3 Rare Neurological Disease Treatment Market Size by Type
2.3.1 Rare Neurological Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Rare Neurological Disease Treatment Market Size Market Share by Type (2018-2023)
2.4 Rare Neurological Disease Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Rare Neurological Disease Treatment Market Size by Application
2.5.1 Rare Neurological Disease Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Rare Neurological Disease Treatment Market Size Market Share by Application (2018-2023)
3 Rare Neurological Disease Treatment Market Size by Player
3.1 Rare Neurological Disease Treatment Market Size Market Share by Players
3.1.1 Global Rare Neurological Disease Treatment Revenue by Players (2018-2023)
3.1.2 Global Rare Neurological Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Rare Neurological Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rare Neurological Disease Treatment by Regions
4.1 Rare Neurological Disease Treatment Market Size by Regions (2018-2023)
4.2 Americas Rare Neurological Disease Treatment Market Size Growth (2018-2023)
4.3 APAC Rare Neurological Disease Treatment Market Size Growth (2018-2023)
4.4 Europe Rare Neurological Disease Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Rare Neurological Disease Treatment Market Size Growth (2018-2023)
5 Americas
5.1 Americas Rare Neurological Disease Treatment Market Size by Country (2018-2023)
5.2 Americas Rare Neurological Disease Treatment Market Size by Type (2018-2023)
5.3 Americas Rare Neurological Disease Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rare Neurological Disease Treatment Market Size by Region (2018-2023)
6.2 APAC Rare Neurological Disease Treatment Market Size by Type (2018-2023)
6.3 APAC Rare Neurological Disease Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Rare Neurological Disease Treatment by Country (2018-2023)
7.2 Europe Rare Neurological Disease Treatment Market Size by Type (2018-2023)
7.3 Europe Rare Neurological Disease Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rare Neurological Disease Treatment by Region (2018-2023)
8.2 Middle East & Africa Rare Neurological Disease Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Rare Neurological Disease Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Rare Neurological Disease Treatment Market Forecast
10.1 Global Rare Neurological Disease Treatment Forecast by Regions (2024-2029)
10.1.1 Global Rare Neurological Disease Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Rare Neurological Disease Treatment Forecast
10.1.3 APAC Rare Neurological Disease Treatment Forecast
10.1.4 Europe Rare Neurological Disease Treatment Forecast
10.1.5 Middle East & Africa Rare Neurological Disease Treatment Forecast
10.2 Americas Rare Neurological Disease Treatment Forecast by Country (2024-2029)
10.2.1 United States Rare Neurological Disease Treatment Market Forecast
10.2.2 Canada Rare Neurological Disease Treatment Market Forecast
10.2.3 Mexico Rare Neurological Disease Treatment Market Forecast
10.2.4 Brazil Rare Neurological Disease Treatment Market Forecast
10.3 APAC Rare Neurological Disease Treatment Forecast by Region (2024-2029)
10.3.1 China Rare Neurological Disease Treatment Market Forecast
10.3.2 Japan Rare Neurological Disease Treatment Market Forecast
10.3.3 Korea Rare Neurological Disease Treatment Market Forecast
10.3.4 Southeast Asia Rare Neurological Disease Treatment Market Forecast
10.3.5 India Rare Neurological Disease Treatment Market Forecast
10.3.6 Australia Rare Neurological Disease Treatment Market Forecast
10.4 Europe Rare Neurological Disease Treatment Forecast by Country (2024-2029)
10.4.1 Germany Rare Neurological Disease Treatment Market Forecast
10.4.2 France Rare Neurological Disease Treatment Market Forecast
10.4.3 UK Rare Neurological Disease Treatment Market Forecast
10.4.4 Italy Rare Neurological Disease Treatment Market Forecast
10.4.5 Russia Rare Neurological Disease Treatment Market Forecast
10.5 Middle East & Africa Rare Neurological Disease Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Rare Neurological Disease Treatment Market Forecast
10.5.2 South Africa Rare Neurological Disease Treatment Market Forecast
10.5.3 Israel Rare Neurological Disease Treatment Market Forecast
10.5.4 Turkey Rare Neurological Disease Treatment Market Forecast
10.5.5 GCC Countries Rare Neurological Disease Treatment Market Forecast
10.6 Global Rare Neurological Disease Treatment Forecast by Type (2024-2029)
10.7 Global Rare Neurological Disease Treatment Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Rare Neurological Disease Treatment Product Offered
11.1.3 Pfizer Rare Neurological Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Rare Neurological Disease Treatment Product Offered
11.2.3 Allergan Rare Neurological Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Rare Neurological Disease Treatment Product Offered
11.3.3 Novartis Rare Neurological Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft Company Information
11.4.2 Bayer Aktiengesellschaft Rare Neurological Disease Treatment Product Offered
11.4.3 Bayer Aktiengesellschaft Rare Neurological Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer Aktiengesellschaft Main Business Overview
11.4.5 Bayer Aktiengesellschaft Latest Developments
11.5 Medtronic
11.5.1 Medtronic Company Information
11.5.2 Medtronic Rare Neurological Disease Treatment Product Offered
11.5.3 Medtronic Rare Neurological Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Medtronic Main Business Overview
11.5.5 Medtronic Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Rare Neurological Disease Treatment Product Offered
11.6.3 Sanofi Rare Neurological Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Rare Neurological Disease Treatment Product Offered
11.7.3 Johnson & Johnson Rare Neurological Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Information
11.8.2 Teva Pharmaceutical Rare Neurological Disease Treatment Product Offered
11.8.3 Teva Pharmaceutical Rare Neurological Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Teva Pharmaceutical Main Business Overview
11.8.5 Teva Pharmaceutical Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Rare Neurological Disease Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Biologics Table 3. Major Players of Organic Compounds Table 4. Rare Neurological Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 5. Global Rare Neurological Disease Treatment Market Size by Type (2018-2023) & ($ Millions) Table 6. Global Rare Neurological Disease Treatment Market Size Market Share by Type (2018-2023) Table 7. Rare Neurological Disease Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 8. Global Rare Neurological Disease Treatment Market Size by Application (2018-2023) & ($ Millions) Table 9. Global Rare Neurological Disease Treatment Market Size Market Share by Application (2018-2023) Table 10. Global Rare Neurological Disease Treatment Revenue by Players (2018-2023) & ($ Millions) Table 11. Global Rare Neurological Disease Treatment Revenue Market Share by Player (2018-2023) Table 12. Rare Neurological Disease Treatment Key Players Head office and Products Offered Table 13. Rare Neurological Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Rare Neurological Disease Treatment Market Size by Regions 2018-2023 & ($ Millions) Table 17. Global Rare Neurological Disease Treatment Market Size Market Share by Regions (2018-2023) Table 18. Global Rare Neurological Disease Treatment Revenue by Country/Region (2018-2023) & ($ millions) Table 19. Global Rare Neurological Disease Treatment Revenue Market Share by Country/Region (2018-2023) Table 20. Americas Rare Neurological Disease Treatment Market Size by Country (2018-2023) & ($ Millions) Table 21. Americas Rare Neurological Disease Treatment Market Size Market Share by Country (2018-2023) Table 22. Americas Rare Neurological Disease Treatment Market Size by Type (2018-2023) & ($ Millions) Table 23. Americas Rare Neurological Disease Treatment Market Size Market Share by Type (2018-2023) Table 24. Americas Rare Neurological Disease Treatment Market Size by Application (2018-2023) & ($ Millions) Table 25. Americas Rare Neurological Disease Treatment Market Size Market Share by Application (2018-2023) Table 26. APAC Rare Neurological Disease Treatment Market Size by Region (2018-2023) & ($ Millions) Table 27. APAC Rare Neurological Disease Treatment Market Size Market Share by Region (2018-2023) Table 28. APAC Rare Neurological Disease Treatment Market Size by Type (2018-2023) & ($ Millions) Table 29. APAC Rare Neurological Disease Treatment Market Size Market Share by Type (2018-2023) Table 30. APAC Rare Neurological Disease Treatment Market Size by Application (2018-2023) & ($ Millions) Table 31. APAC Rare Neurological Disease Treatment Market Size Market Share by Application (2018-2023) Table 32. Europe Rare Neurological Disease Treatment Market Size by Country (2018-2023) & ($ Millions) Table 33. Europe Rare Neurological Disease Treatment Market Size Market Share by Country (2018-2023) Table 34. Europe Rare Neurological Disease Treatment Market Size by Type (2018-2023) & ($ Millions) Table 35. Europe Rare Neurological Disease Treatment Market Size Market Share by Type (2018-2023) Table 36. Europe Rare Neurological Disease Treatment Market Size by Application (2018-2023) & ($ Millions) Table 37. Europe Rare Neurological Disease Treatment Market Size Market Share by Application (2018-2023) Table 38. Middle East & Africa Rare Neurological Disease Treatment Market Size by Region (2018-2023) & ($ Millions) Table 39. Middle East & Africa Rare Neurological Disease Treatment Market Size Market Share by Region (2018-2023) Table 40. Middle East & Africa Rare Neurological Disease Treatment Market Size by Type (2018-2023) & ($ Millions) Table 41. Middle East & Africa Rare Neurological Disease Treatment Market Size Market Share by Type (2018-2023) Table 42. Middle East & Africa Rare Neurological Disease Treatment Market Size by Application (2018-2023) & ($ Millions) Table 43. Middle East & Africa Rare Neurological Disease Treatment Market Size Market Share by Application (2018-2023) Table 44. Key Market Drivers & Growth Opportunities of Rare Neurological Disease Treatment Table 45. Key Market Challenges & Risks of Rare Neurological Disease Treatment Table 46. Key Industry Trends of Rare Neurological Disease Treatment Table 47. Global Rare Neurological Disease Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 48. Global Rare Neurological Disease Treatment Market Size Market Share Forecast by Regions (2024-2029) Table 49. Global Rare Neurological Disease Treatment Market Size Forecast by Type (2024-2029) & ($ Millions) Table 50. Global Rare Neurological Disease Treatment Market Size Forecast by Application (2024-2029) & ($ Millions) Table 51. Pfizer Details, Company Type, Rare Neurological Disease Treatment Area Served and Its Competitors Table 52. Pfizer Rare Neurological Disease Treatment Product Offered Table 53. Pfizer Rare Neurological Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 54. Pfizer Main Business Table 55. Pfizer Latest Developments Table 56. Allergan Details, Company Type, Rare Neurological Disease Treatment Area Served and Its Competitors Table 57. Allergan Rare Neurological Disease Treatment Product Offered Table 58. Allergan Main Business Table 59. Allergan Rare Neurological Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 60. Allergan Latest Developments Table 61. Novartis Details, Company Type, Rare Neurological Disease Treatment Area Served and Its Competitors Table 62. Novartis Rare Neurological Disease Treatment Product Offered Table 63. Novartis Main Business Table 64. Novartis Rare Neurological Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 65. Novartis Latest Developments Table 66. Bayer Aktiengesellschaft Details, Company Type, Rare Neurological Disease Treatment Area Served and Its Competitors Table 67. Bayer Aktiengesellschaft Rare Neurological Disease Treatment Product Offered Table 68. Bayer Aktiengesellschaft Main Business Table 69. Bayer Aktiengesellschaft Rare Neurological Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 70. Bayer Aktiengesellschaft Latest Developments Table 71. Medtronic Details, Company Type, Rare Neurological Disease Treatment Area Served and Its Competitors Table 72. Medtronic Rare Neurological Disease Treatment Product Offered Table 73. Medtronic Main Business Table 74. Medtronic Rare Neurological Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 75. Medtronic Latest Developments Table 76. Sanofi Details, Company Type, Rare Neurological Disease Treatment Area Served and Its Competitors Table 77. Sanofi Rare Neurological Disease Treatment Product Offered Table 78. Sanofi Main Business Table 79. Sanofi Rare Neurological Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 80. Sanofi Latest Developments Table 81. Johnson & Johnson Details, Company Type, Rare Neurological Disease Treatment Area Served and Its Competitors Table 82. Johnson & Johnson Rare Neurological Disease Treatment Product Offered Table 83. Johnson & Johnson Main Business Table 84. Johnson & Johnson Rare Neurological Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 85. Johnson & Johnson Latest Developments Table 86. Teva Pharmaceutical Details, Company Type, Rare Neurological Disease Treatment Area Served and Its Competitors Table 87. Teva Pharmaceutical Rare Neurological Disease Treatment Product Offered Table 88. Teva Pharmaceutical Main Business Table 89. Teva Pharmaceutical Rare Neurological Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 90. Teva Pharmaceutical Latest Developments List of Figures Figure 1. Rare Neurological Disease Treatment Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Rare Neurological Disease Treatment Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Rare Neurological Disease Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Rare Neurological Disease Treatment Sales Market Share by Country/Region (2022) Figure 8. Rare Neurological Disease Treatment Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Rare Neurological Disease Treatment Market Size Market Share by Type in 2022 Figure 10. Rare Neurological Disease Treatment in Hospital Pharmacies Figure 11. Global Rare Neurological Disease Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions) Figure 12. Rare Neurological Disease Treatment in Retail Pharmacies Figure 13. Global Rare Neurological Disease Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions) Figure 14. Rare Neurological Disease Treatment in Online Pharmacies Figure 15. Global Rare Neurological Disease Treatment Market: Online Pharmacies (2018-2023) & ($ Millions) Figure 16. Global Rare Neurological Disease Treatment Market Size Market Share by Application in 2022 Figure 17. Global Rare Neurological Disease Treatment Revenue Market Share by Player in 2022 Figure 18. Global Rare Neurological Disease Treatment Market Size Market Share by Regions (2018-2023) Figure 19. Americas Rare Neurological Disease Treatment Market Size 2018-2023 ($ Millions) Figure 20. APAC Rare Neurological Disease Treatment Market Size 2018-2023 ($ Millions) Figure 21. Europe Rare Neurological Disease Treatment Market Size 2018-2023 ($ Millions) Figure 22. Middle East & Africa Rare Neurological Disease Treatment Market Size 2018-2023 ($ Millions) Figure 23. Americas Rare Neurological Disease Treatment Value Market Share by Country in 2022 Figure 24. United States Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 25. Canada Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 26. Mexico Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 27. Brazil Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 28. APAC Rare Neurological Disease Treatment Market Size Market Share by Region in 2022 Figure 29. APAC Rare Neurological Disease Treatment Market Size Market Share by Type in 2022 Figure 30. APAC Rare Neurological Disease Treatment Market Size Market Share by Application in 2022 Figure 31. China Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 32. Japan Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 33. Korea Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 34. Southeast Asia Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 35. India Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 36. Australia Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 37. Europe Rare Neurological Disease Treatment Market Size Market Share by Country in 2022 Figure 38. Europe Rare Neurological Disease Treatment Market Size Market Share by Type (2018-2023) Figure 39. Europe Rare Neurological Disease Treatment Market Size Market Share by Application (2018-2023) Figure 40. Germany Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 41. France Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 42. UK Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 43. Italy Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 44. Russia Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 45. Middle East & Africa Rare Neurological Disease Treatment Market Size Market Share by Region (2018-2023) Figure 46. Middle East & Africa Rare Neurological Disease Treatment Market Size Market Share by Type (2018-2023) Figure 47. Middle East & Africa Rare Neurological Disease Treatment Market Size Market Share by Application (2018-2023) Figure 48. Egypt Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 49. South Africa Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 50. Israel Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 51. Turkey Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 52. GCC Country Rare Neurological Disease Treatment Market Size Growth 2018-2023 ($ Millions) Figure 53. Americas Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 54. APAC Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 55. Europe Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 56. Middle East & Africa Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 57. United States Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 58. Canada Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 59. Mexico Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 60. Brazil Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 61. China Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 62. Japan Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 63. Korea Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 64. Southeast Asia Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 65. India Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 66. Australia Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 67. Germany Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 68. France Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 69. UK Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 70. Italy Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 71. Russia Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 72. Spain Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 73. Egypt Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 74. South Africa Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 75. Israel Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 76. Turkey Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 77. GCC Countries Rare Neurological Disease Treatment Market Size 2024-2029 ($ Millions) Figure 78. Global Rare Neurological Disease Treatment Market Size Market Share Forecast by Type (2024-2029) Figure 79. Global Rare Neurological Disease Treatment Market Size Market Share Forecast by Application (2024-2029)
